Viral hepatitis is caused by at least two immunologically distinct infectious agents: virus A, the etiological agent of infectious, epidemic or shortincubation hepatitis (hepatitis A), and virus B, which is responsible for serum hepatitis or longincubation hepatitis (hepatitis B). The discovery of Australia antigen, now generally referred to as hepatitis B antigen, has provided a specific serological marker of infection with or carriage of type B hepatitis virus. This finding has resulted in considerable progress in the understanding of the epidemiology and immunology of this form of hepatitis and its sequele and more recently in tissue culture work. On the other hand, it is remarkable that in comparison with type B hepatitis there appears to have been little progress with type A hepatitis, although marmosets now seem to offer a suitable model for the study of this form of hepatitis.
Epidemiology ofInfections with Hepatitis B Virus
The existence of at least two distinct types of acute hepatitis in man, differing by their incubation periods and primary modes of transmission, has been known for many years. This has been confirmed by careful clinical observations and transmission experiments to human volunteers. Epidemiological studies and limited surveys have demonstrated that both types of viral hepatitis are worldwide in distribution.
The epidemiological concepts of hepatitis B infection have recently undergone a significant change (Zuckerman 1972a) . The demonstration that the hepatitis B agent was infective by mouth and the finding that the infection was endemic in closed institutions, the prevalence of infection in adults in urban communities, the carrier rate and age distribution of hepatitis B antigen in different geographical regions and the relatively high incidence in poor socio-economic environments, have altered the epidemiological dogma that hepatitis B was spread exclusively by blood and blood products through the parenteral route. Some evidence is also available for the transmission of hepatitis B by intimate personal contact and possibly by the venereal route. Although the modes of transmission of this infection in the tropics are similar to those in other parts of the world, additional factors may be of importance, including traditional tattooing and scarification, ritual circumcision and repeated biting by bloodsucking arthropod vectors.
Preliminary results of investigations into the role which biting insects may play in the spread of hepatitis B are conflicting. No consistent association could be found between the notification of hepatitis and the months of high or low rainfall or with the period immediately after the rains in 8 countries in Africa and Latin America (Cockburn 1972) . Although this does not excluck the possibility that biting insects may play a role in the spread of hepatitis, these observations imply that those mosquitoes which multiply with the rains may not be involved. In a study in New Guinea the incidence of hepatitis B antigen was compared, in the same population, with that of antibody to several arboviruses of groups A and B (Hawkes et al. 1972) . The incidence of arbovirus antibodies correlated strongly with that of mosquito activity and it was inversely related to altitude. On the other hand, the incidence of detectable hepatitis B antigen was not related to either mosquito activity or to altitude. The preva-lence of arbovirus antibodies in the population also increased cumulatively with age, whereas the incidence of hepatitis B antigen did not increase significantly with age. Moreover the different prevalence rates of antigen among ethnic groups living in the same geographical areas are inconsistent with vector-borne infection. There is, however, one report which is yet to be confirmed, that some species of mosquito may serve as biological vectors for hepatitis B infection . More recently, pools of mosquitoes caught in the wild in Kenya and Uganda were tested for hepatitis B antigen using the solid-phase radioimmunoassay technique (Prince et al. 1972) . The antigen was detected in a number of the mosquito pools representing 8 different species. It appeared likely that mosquitoes may play a passive mechanical role in the transmission of hepatitis B. The high prevalence of a persistent carrier rate in populations in the tropics may be due to the frequency of exposure to blood-sucking arthropod vectors in early life at an age when the cell-mediated immune response is not yet fully developed thereby resulting in chronic infection.
Subtypes ofHepatitis B Antigen
Differences in the way various human antisera react in the immunodiffusion test against hepatitis B antigen have in general been attributed to differences in the relative concentration of antigen and antibody. However, the observation of incomplete fusion of precipitin lines, and the formation of spurs when the same antigens were tested against different antisera showed that the two adjacent antigens were related but not identical.
When the same antigens were tested against other antisera the precipitin lines gave reactions of identity with no spurs. A number of different surface antigenic reactivities have thus been demonstrated and these provide an important additional technique for epidemiological studies.
Nature ofHepatitis B Antigen
The biophysical and biochemical properties of hepatitis B antigen are the subject of intensive studies in many laboratories. The antigen is a protein with a varying amount of lipid. It is immunologically distinct from normal low-density serum lipoproteins and the buoyant density of the antigen-bearing particles is intermediate between that of serum lipoproteins and most other serum proteins. The sedimentation coefficient of antigenic activity has been variously found to be intermediate between that of IgM (19S) and 'empty' poliovirus capsids (73S).
Howard & Zuckerman (1973) fractionated hepatitis B antigen in an electrofocusing column using a sucrose gradient to which a mixture of ampholytes was added to a final concentration of 1 %. The samples were fractionated in the pH gradient in an electric field. The results suggested that there are at least two isoelectric points for the antigen, one which is clearly defined at pH 3.6 and a second more diffuse zone over the pH range 4.1 to 4.6. Preliminary analysis on 10% SDSpolyacrylamide gels indicates that there may be at least one additional component in the 4.1 to 4.6 range, which is not present in the fraction collected at pH 3.6 (Fig 1) . It is uncertain whether hepatitis B antigen represents incomplete virus particles, aggregates of protein subunits, excess virus-coat material, overproduction of unstable virus-like particles or a modified cellular component whose synthesis is coded for or specifically derepressed by the hepatitis B virus. There is only one report in the literature on the finding of about 5 % RNA in antigen partially purified from serum and another on the detection ofan RNA-dependent DNA polymerase in pellets of antigen concentrated by ultracentrifugation from sera of patients with hepatitis. If these observations can be confirmed then a logical deduction is that the antigen is indeed associated with an RNA virus.
The morphology of hepatitis B antigen shares a number of features with known viral structure (Zuckerman 1969 (Zuckerman , 1972b . The principal antigenic constituent is a rather pleomorphic spherical particle measuring about 20 nm in diameter but with a range of 16-25 nm. The presence of tubular forms, with an average diameter of 20 nm and often several hundred nanometres in length, is a characteristic feature. The third type of particle is also spheroidal, measuring about 42 nm in diameter, with an inner core of about 28 nm in .20 diameter, a 2 nm shell and an outer coat about 7 nm in thickness (Fig 2) . Almeida et al. (1971) noted that after detergent treatment of pellets ofhepatitis B antigen obtained by ultracentrifugation of whole serum, the large 42 nm spheroidal particles separated into an outer coat of antigen and an inner component which was 27 nm in diameter. The inner component resembled morphologically a rhinovirus. Antibody present in the serum of patients after recovery from type B hepatitis reacted with the inner component, but not with the outer hepatitis B antigen component, to yield immune aggregates resembling those seen in homogenates of liver taken post mortem from patients with hepatitis B. Antibody to the inner core was absent from the pre-hepatitis sera from the same convalescent patients. It was suggested that antibody to hepatitis B antigen develops during the course of the infection, but that it is subsequently cleared from the serum with clinical improvement, while a normal immune response is produced to the inner core of the 42 nm particle. These findings have since been confirmed elsewhere and lend support to the view that the inner component may indeed represent the infectious agent of type B hepatitis, but final confirmation must await the successful cultivation of the infectious agent.
Section ofPathology

Tissue and Organ Culture Studies ofHepatitis Type B
Methods have been developed in recent years for obtaining primary cultures of differentiated hepatocytes from human embryo and adult livers (Zuckerman 1970) and the induction of progressive noncytopathic involvement of cellular components of monolayer cultures of human embryo liver cells after inoculation with a known infective hepatitis B serum has been reported (Brighton et al. 1971 ). Cytoplasmic and nuclear involvement was demonstrated by the direct immunofluorescent antibody technique using an antiserum of human origin, and, more recently, cytoplasmic fluorescence with antibody raised in guinea-pigs. Similar fluorescent changes were observed in the cells of liver cultures inoculated with supernatant fluid which had been passaged in culture twice. The development of fluorescence was blocked by appropriate blocking experiments. The same noncytocidal changes have since been demonstrated with another two sera of different origin. Similar results have now also been reported by Smith & Francis (1972) .
Almost identical fluorescent changes were also observed in liver cells cultured from biopsy material obtained from 2 patients with circulating hepatitis B antigen (Coyne et al. 1971 ). In addi-22 tion, the antigen was detected by radioimmunoprecipitation in the supernatant fluid of a few cultures. Coyne et al. concluded that hepatitis B antigen can be passaged in cultured liver cells and that it was highly probable that an increase in antigen resulted from replication in vitro.
The morphological and functional capacity of cells maintained in organ culture may offer a system for cultivating viruses which closely simulates conditions in the intact host. Examples of the specificity of effect on the target organ and differential susceptibility of different hosts are found within each class of virus, and organ cultures have reproduced many but not all of the phenomena of specificity observed in the intact animal. Furthermore, organ culture techniques have proved valuable for the cultivation of viruses which are difficult to grow in conventional monolayer cell cultures.
Cultured fragments of human inguinal lymph nodes obtained at the time of herniorrhaphy from 4 children were incubated immediately with serum containing hepatitis B antigen from a drug addict admitted to hospital with hepatitis (Jenson et al. 1970 ). The pooled 4-and 6-day fluids harvested from one of four groups of the lymph node organ cultures produced a faint but definite precipitin line for hepatitis B antigen by the immunodiffusion technique and a titre of 1:20 was obtained by complement fixation. The three types of particles generally associated with the antigen were found by negative staining in the original serum and also in the pooled organ culture fluid. However, whereas the large double-shelled 36-44 nm particles were sparse in the original inoculum, the three types of particlessmall spherical, tubular and large spheroidal structureswere present in almost equal number in the harvested organ culture fluid. Ultra-thin sections of these explants revealed both intracellular and extracellular clusters of antigen-like particles. It was concluded that some lymph node organ cultures may support the in vitro production of hepatitis B antigen.
More recently, Zuckerman et al. (1972) reported that hepatitis B antigen may be produced in human embryo liver organ cultures. A progressive rise in the titre of hepatitis B antigen, as measured by several techniques, has so far been demonstrated with 2 different sera, and positive results were obtained by one or more techniques at 7-9 days, with 4 additional sera. One successful passage of harvested material from cultures on Day 8 has also been accomplished with 2 specimens. Further studies are, of course, required to extend these observations and adaptation to growth in conventional cell cultures is most important and urgent because the difficulty in obtaining suitable fresh human feetal liver is an obvious limitation to this type of work.
The susceptibility of rhesus monkeys to human type B hepatitis (London et al. 1972 ) prompted studies on the feasibility of using liver organ cultures from newly killed subhuman primates (Taylor & Kelen 1972) . Fluid harvested 8 days after inoculation of rhesus monkey liver cultures with serum containing hepatitis B antigen was found to contain readily detectable quantities of antigen by complement fixation and immune electron microscopy. There was also a substantial increase in the proportion of the large 40 nm particles of hepatitis B antigen. Serial passage of harvested fluids from these organ cultures has not yet been achieved. Baines & Zuckerman (1973) have since confirmed that liver organ cultures from newly killed rhesus monkeys can be established successfully and that such preparations may provide a possible in vitro model for investigating type B hepatitis. It appeared, however, that the liver cultures from rhesus monkeys were less efficient than preparations derived from human embryo livers.
These reports on the attempted cultivation of the hepatitis B agent in tissue and organ cultures derived from human and non-human primates are thus encouraging, but further studies are clearly required to determine whether replication of the virus associated with hepatitis B antigen can be readily established as a practical tool for investigating the biological characteristics of this infectious agent or whether the reported production of the antigen in culture is the result of abortive infection.
Handling biological materials always entails some risk of infection, particularly if of human origin, and especially if from sick patients. The risk may be expected from the nature of the illness (e.g. smallpox, hepatitis) or type of specimen (e.g. sputum, faces). The risk may be unsuspected when the patient's illness is nonspecific in character or inadequately described, or where specimens of body fluid are treated merely as 'chemicals', disregarding such possibilities as bacteraemia and vireemia. Awareness of risk and good technique are more important for safety than physical facilities. The virologist must remember the possibility of bacterial pathogens (e.g. tuberculosis, typhoid), the bacteriologist must remember viruses (e.g. hepatitis), and other laboratory workers must remember both viruses and bacteria, especially when dealing with body fluids.
Problems of hepatitis in the laboratory were considered in detail in reports under the chairmanship of Maycock (1972) and Rosenheim (1972) . One may re-emphasize the importance of skin pricks, soiling of broken skin, splashing of eyes, oral contamination, and possibly inhalation of aerosols. The risk is apparently dose-related, higher with materials from patients on renal dialysis, having organ transplantation, or on immunosuppressants. Safety was also dealt with in a recent official booklet (Department of Health and Social Security & Welsh Office: Working Party of Central Pathology Committee 1972), though some of these recommendations are contestable. Thus my personal practice is to leave the plastic sheath of a needle where, after completing use of a syringe and needle, it can be picked up safely on to the needle and firmed into position by forceps or guarded fingers, thus producing a nontraumatic object for further disposal. Ordinary fabric masks do not protect the wearer, give a false sense of security, and become uncomfortable provoking dangerous handling for readjustment. Disposal of bulk fluids is best done via the autoclave rather than by use of chemical agents, not by aspiration which is likely to contaminate the pump and effluent by aerosol. Glutaraldehyde is preferable to formalin where hypochlorite cannot be used, but prompt washing of contaminated skin is more important than chemical treatment.
In order to obtain some factual evidence about hepatitis in laboratories, the Microbiology Subcommittee of the Association of Clinical Pathologists asked me to undertake a survey of its members by questionnaire. A preliminary survey showed that cases of hepatitis were reported from 58 (20%) of 285 laboratories in the period 1964-69 and in 32 (11 %) of 289 laboratories in the single year 1970, suggesting a rising incidence, but with little difference by main discipline of work. Most of the 127 hepatitis cases were technicians (87 against 16 medical, 5 nonmedical graduates, 19 'others'); of the employment disciplines, biochemistry led with 48 cases against 32 for hmmato- 
